Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00GIW
|
|||
Former ID |
DNC013098
|
|||
Drug Name |
1-(3,5-dibromobenzyl)-1H-imidazole
|
|||
Synonyms |
CHEMBL211276; 528543-94-4; 1-(3,5-dibromobenzyl)-1H-imidazole; CTK1G1925; DTXSID30658795; BDBM50188091; 1-[(3,5-Dibromophenyl)methyl]-1H-imidazole; 1H-Imidazole, 1-[(3,5-dibromophenyl)methyl]-
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C10H8Br2N2
|
|||
Canonical SMILES |
C1=CN(C=N1)CC2=CC(=CC(=C2)Br)Br
|
|||
InChI |
1S/C10H8Br2N2/c11-9-3-8(4-10(12)5-9)6-14-2-1-13-7-14/h1-5,7H,6H2
|
|||
InChIKey |
QXITVPZFTOHIGY-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 528543-94-4
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Steroid 17-alpha-monooxygenase (S17AH) | Target Info | Inhibitor | [1] |
BioCyc | Superpathway of steroid hormone biosynthesis | |||
Glucocorticoid biosynthesis | ||||
Androgen biosynthesis | ||||
KEGG Pathway | Steroid hormone biosynthesis | |||
Metabolic pathways | ||||
Ovarian steroidogenesis | ||||
Prolactin signaling pathway | ||||
Pathwhiz Pathway | Androgen and Estrogen Metabolism | |||
Steroidogenesis | ||||
Reactome | Androgen biosynthesis | |||
Glucocorticoid biosynthesis | ||||
Endogenous sterols | ||||
WikiPathways | Metapathway biotransformation | |||
Steroid Biosynthesis | ||||
Oxidation by Cytochrome P450 | ||||
Metabolism of steroid hormones and vitamin D | ||||
Glucocorticoid & Mineralcorticoid Metabolism | ||||
Prostate Cancer | ||||
Phase 1 - Functionalization of compounds |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and biochemical evaluation of a range of potent benzyl imidazole-based compounds as potential inhibitors of the enzyme complex 17alpha-hy... Bioorg Med Chem Lett. 2006 Aug 1;16(15):4011-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.